Sinocare Résultats passés
Passé contrôle des critères 1/6
Sinocare has been growing earnings at an average annual rate of 8.3%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 21.2% per year. Sinocare's return on equity is 5.3%, and it has net margins of 5.3%.
Informations clés
8.3%
Taux de croissance des bénéfices
9.2%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 16.0% |
Taux de croissance des recettes | 21.2% |
Rendement des fonds propres | 5.3% |
Marge nette | 5.3% |
Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings
Nov 02Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture
May 02Recent updates
We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings
Nov 02Estimating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)
Oct 23Sinocare (SZSE:300298) Is Reinvesting At Lower Rates Of Return
Oct 03Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings
Aug 07Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)
Jul 19Is Sinocare (SZSE:300298) A Risky Investment?
Jun 07Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture
May 02Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark
Apr 22Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return
Apr 03Ventilation des recettes et des dépenses
Comment Sinocare gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Sep 24 | 4,206 | 222 | 1,582 | 389 |
30 Jun 24 | 4,184 | 307 | 1,530 | 366 |
31 Mar 24 | 4,190 | 306 | 1,468 | 376 |
31 Dec 23 | 4,059 | 284 | 1,431 | 356 |
30 Sep 23 | 4,137 | 379 | 1,406 | 332 |
30 Jun 23 | 4,110 | 392 | 1,383 | 325 |
31 Mar 23 | 4,215 | 441 | 1,389 | 331 |
01 Jan 23 | 3,952 | 447 | 1,335 | 306 |
30 Sep 22 | 3,463 | 296 | 1,217 | 259 |
30 Jun 22 | 3,081 | 218 | 1,148 | 234 |
31 Mar 22 | 2,478 | 128 | 990 | 192 |
01 Jan 22 | 2,361 | 108 | 971 | 182 |
30 Sep 21 | 2,235 | 134 | 993 | 194 |
30 Jun 21 | 2,174 | 147 | 927 | 193 |
31 Mar 21 | 2,095 | 168 | 858 | 190 |
31 Dec 20 | 2,015 | 187 | 788 | 182 |
30 Sep 20 | 2,049 | 287 | 724 | 187 |
30 Jun 20 | 1,936 | 280 | 695 | 173 |
31 Mar 20 | 1,831 | 265 | 672 | 164 |
31 Dec 19 | 1,778 | 251 | 653 | 161 |
30 Sep 19 | 1,651 | 286 | 613 | 137 |
30 Jun 19 | 1,604 | 272 | 587 | 140 |
31 Mar 19 | 1,607 | 276 | 591 | 134 |
31 Dec 18 | 1,551 | 310 | 588 | 129 |
30 Sep 18 | 1,429 | 286 | 543 | 123 |
30 Jun 18 | 1,301 | 333 | 452 | 131 |
31 Mar 18 | 1,112 | 296 | 392 | 100 |
01 Jan 18 | 1,033 | 258 | 352 | 74 |
30 Sep 17 | 994 | 206 | 346 | 49 |
30 Jun 17 | 945 | 156 | 376 | 0 |
31 Mar 17 | 849 | 116 | 361 | 0 |
31 Dec 16 | 796 | 115 | 346 | 0 |
30 Sep 16 | 722 | 138 | 328 | 0 |
30 Jun 16 | 674 | 121 | 327 | 0 |
31 Mar 16 | 698 | 155 | 317 | 0 |
31 Dec 15 | 646 | 144 | 302 | 0 |
30 Sep 15 | 634 | 176 | 266 | 0 |
30 Jun 15 | 611 | 191 | 236 | 0 |
31 Mar 15 | 570 | 199 | 207 | 0 |
31 Dec 14 | 545 | 197 | 195 | 0 |
30 Sep 14 | 506 | 191 | 178 | 0 |
30 Jun 14 | 488 | 176 | 167 | 0 |
31 Mar 14 | 450 | 157 | 160 | 0 |
31 Dec 13 | 449 | 165 | 150 | 0 |
Des revenus de qualité: 300298 has a large one-off loss of CN¥115.8M impacting its last 12 months of financial results to 30th September, 2024.
Augmentation de la marge bénéficiaire: 300298's current net profit margins (5.3%) are lower than last year (9.2%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 300298's earnings have grown by 8.3% per year over the past 5 years.
Accélération de la croissance: 300298's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 300298 had negative earnings growth (-41.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Rendement des fonds propres
ROE élevé: 300298's Return on Equity (5.3%) is considered low.